Highlights from FDA Regulatory Developments in Clinical Trials: 2023 Recap and 2024 Forecast

In this episode, Rebecca Schaefer, Michael Hinckle, and Elisabeth Lewis summarize FDA regulatory developments from 2023 and what to expect in 2024 as it relates to clinical research. They discuss the significance of the decentralized clinical trials guidance documents, highlights of the Informed Consent Guidance document, the impacts of FDA's final rule on IRB waivers of consent, the IRB review of individual patient expanded access submissions, and the potential effects of the new proposed rule for lab developed tests.

You can listen to Highlights from FDA Regulatory Developments in Clinical Trials: 2023 Recap and 2024 Forecast online on Radio and Podcast. Open the player on this page to stream the available audio.

Highlights from FDA Regulatory Developments in Clinical Trials: 2023 Recap and 2024 Forecast is an episode from K&L Gates Health Care Triage by K&L Gates.

This episode is 15:54 long.

This episode was published on Mar 5, 2024.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from K&L Gates Health Care Triage when more episodes are available from the podcast feed.